ID: ALA118898

Max Phase: Preclinical

Molecular Formula: C19H15NO2

Molecular Weight: 289.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(C(=Cc2ccccn2)c2ccc(O)cc2)cc1

Standard InChI:  InChI=1S/C19H15NO2/c21-17-8-4-14(5-9-17)19(13-16-3-1-2-12-20-16)15-6-10-18(22)11-7-15/h1-13,21-22H

Standard InChI Key:  IDDZZJIJKOUMOD-UHFFFAOYSA-N

Associated Targets(non-human)

Estrogen receptor 420 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 289.33Molecular Weight (Monoisotopic): 289.1103AlogP: 4.08#Rotatable Bonds: 3
Polar Surface Area: 53.35Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.04CX Basic pKa: 4.50CX LogP: 4.16CX LogD: 4.14
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.76Np Likeness Score: -0.25

References

1. Meyers MJ, Carlson KE, Katzenellenbogen JA..  (1998)  Facile synthesis of high affinity styrylpyridine systems as inherently fluorescent ligands for the estrogen receptor.,  (24): [PMID:9934476] [10.1016/s0960-894x(98)00652-0]

Source